The stock has been in consolidation phase since january 2018 and could not breach 888 and 1039 resistance respectively however lately the stock has smashed both of them and rallied to an unstoppable territory
The volumes also indicate pretty good buying also DIIs have increased their holdings in the stock
The company formed cup and handle in 2019 but failed badly nevertheless the stock rebounded pretty well and gave a pretty goood breakout lately
The company has more than 132 patents and is engaged in pharmaceuticals , contract research and development services
TARGET - 1800
The volumes also indicate pretty good buying also DIIs have increased their holdings in the stock
The company formed cup and handle in 2019 but failed badly nevertheless the stock rebounded pretty well and gave a pretty goood breakout lately
The company has more than 132 patents and is engaged in pharmaceuticals , contract research and development services
TARGET - 1800
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。